Kezar Life Sciences, Inc. — Director's Dealing 2020

Feb 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2020-02-04

Reporting Person: BERGER FRANKLIN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-04	Common Stock	P	120846	$2.60	Acquired	684003	Direct

Footnotes

F1: Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.